# Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer

## Primary tabs

Bibliographic reference | Neymark, N. ; Adriaenssen, I ; Gorlia, Thierry ; Caleo, S ; Bolla, M.. Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer. In: Health Economics, Vol. 11, no. 3, p. 233-248 (2002) |
---|---|

Permanent URL | http://hdl.handle.net/2078.1/42281 |

## References Provided by I4OC

- Neymark Niels,
*Assessing the Economic Value of Anticancer Therapies*, ISBN:9783642721250, 10.1007/978-3-642-72123-6 - Iveson T.J., Hickish T., Schmitt C., Van Cutsem E.,
*Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FU*, 10.1016/s0959-8049(99)00186-0 - McGuire W, Neugut A I, Arikian S, Doyle J, Dezii C M,
*Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancer.*, 10.1200/jco.1997.15.2.640 - Thompson S. G,
*How should cost data in pragmatic randomised trials be analysed?*, 10.1136/bmj.320.7243.1197 - Briggs Andrew, Gray Alastair,
*The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation*, 10.1177/135581969800300410 - Hougaard Philip,
*Analysis of Multivariate Survival Data*, ISBN:9781461270874, 10.1007/978-1-4612-1304-8 - Moeschberger M. L., Klein John P.,
*A Comparison of Several Methods of Estimating the Survival Function When There is Extreme Right Censoring*, 10.2307/2530660 - Pepe Margaret Sullivan, Fleming Thomas R.,
*Weighted Kaplan-Meier Statistics: A Class of Distance Tests for Censored Survival Data*, 10.2307/2531492 - Wright Janice C., Weinstein Milton C.,
*Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes*, 10.1056/nejm199808063390606 - Collett D.,
*Modelling Survival Data in Medical Research*, ISBN:9780412448904, 10.1007/978-1-4899-3115-3 - Survival Analysis. Techniques for Censored and Truncated Data. Springer: New York, 1997.
- Irwin J. O.,
*The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice*, 10.1017/s0022172400014443 - Karrison Theodore G.,
*Use of Irwin's restricted mean as an index for comparing survival in different treatment groups—Interpretation and power considerations*, 10.1016/s0197-2456(96)00089-x - Pisters,
*Semin Oncol*,**26**, 202 (1999) - Horwitz Eric M., Hanlon Alexandra L., Hanks Gerald E.,
*Update on the treatment of prostate cancer with external beam irradiation*, 10.1002/(sici)1097-0045(19981101)37:3<195::aid-pros10>3.0.co;2-c - Bolla Michel, Gonzalez Dionisio, Warde Padraig, Dubois Jean Bernard, Mirimanoff René-Olivier, Storme Guy, Bernier Jacques, Kuten Abraham, Sternberg Cora, Gil Thierry, Collette Laurence, Pierart Marianne,
*Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin*, 10.1056/nejm199707313370502 - Guide Pratique des Médicament. Maloine: Paris, 1996.
- Nomenclature Générale des Actes Professionel. Union des Caisses Nationales de Sécurités Sociales: Paris, 1994.
- Dictionnaire VIDA. Editions du Vidal: Paris, 1998.
- World Bank. World Health Development Report. Washington, DC, 1993.
- Cost-Effectiveness in Health and Medicin. Oxford University Press: New York, 1996.
- Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S V, Mantel N, McPherson K, Peto J, Smith P G,
*Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples*, 10.1038/bjc.1977.1 - Mark Daniel B., Hlatky Mark A., Califf Robert M., Naylor C. David, Lee Kerry L., Armstrong Paul W., Barbash Gabriel, White Harvey, Simoons Maarten L., Nelson Charlotte L., Clapp-Channing Nancy, Knight J. David, Harrell Frank E., Simes John, Topol Eric J.,
*Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction*, 10.1056/nejm199505253322106 - Messori A.,
*Survival curve fitting using the Gompertz function: a methodology for conducting cost-effectiveness analyses on mortality data*, 10.1016/s0169-2607(96)01788-9 - Messori A., Becagli P., Trippoli S., Tendi E.,
*A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma*, 10.1016/s0959-8049(96)00413-3 - Garg Mohan L., Rao B. Raja, Redmond Carol K.,
*Maximum-Likelihood Estimation of the Parameters of the Gompertz Survival Function*, 10.2307/2346545 - Cantor Alan B., Shuster Jonathan J.,
*Parametric versus non-parametric methods for estimating cure rates based on censored survival data*, 10.1002/sim.4780110710 - Lin D. Y., Feuer E. J., Etzioni R., Wax Y.,
*Estimating Medical Costs from Incomplete Follow-Up Data*, 10.2307/2533947 - Briggs Andrew H., Mooney Christopher Z., Wonderling David E.,
*Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation*, 10.1002/(sici)1097-0258(19991215)18:23<3245::aid-sim314>3.0.co;2-2 - Heitjan Daniel F., Moskowitz Alan J., Whang William,
*Bayesian estimation of cost-effectiveness ratios from clinical trials*, 10.1002/(sici)1099-1050(199905)8:3<191::aid-hec409>3.0.co;2-r - Briggs Andrew, Fenn Paul,
*Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane*, 10.1002/(sici)1099-1050(199812)7:8<723::aid-hec392>3.0.co;2-o - Briggs Andrew H.,
*A Bayesian approach to stochastic cost-effectiveness analysis*, 10.1002/(sici)1099-1050(199905)8:3<257::aid-hec427>3.0.co;2-e - O'Brien Bernie, Gafni Amiram,
*When Do the "Dollars" Make Sense? : Toward a Conceptual Framework for Contingent Valuation Studies in Health Care*, 10.1177/0272989x9601600314 - Bolla M., Collette L., Gonzalez D., Warde P., Dubois J.B., Mirimanoff R., Storme G., Bernier J., Kuten A., Piérart M.,
*Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy — A phase III EORTC study*, 10.1016/s0959-8049(99)80699-6 - Glasziou Paul P., Cole Bernard F., Gelber Richard D., Hilden Jorgen, Simes R. John,
*Quality adjusted survival analysis with repeated quality of life measures*, 10.1002/(sici)1097-0258(19980615)17:11<1215::aid-sim844>3.0.co;2-y - Glick,
*Med Decision Making*,**18**, 63 (1998) - Carides G. W.,
*A regression-based method for estimating mean treatment cost in the presence of right-censoring*, 10.1093/biostatistics/1.3.299 - Glick Henry A., Polsky Daniel, Willke Richard J., Schulman Kevin A.,
*A Comparison of Preference Assessment Instruments Used in a Clinical Trial : Responses to the Visual Analog Scale from the EuroQol EQ-5D and the Health Utilities Index*, 10.1177/0272989x9901900305